Abstract
According to 1997 estimates, 59,700,700 Americans (about 22% of the U.S. population) have one or more forms of cardiovascular disease (CVD). The statistics on the cause of death are even worse: 41.2% of all deaths are caused by some form of CVD [1]. Occlusive arterial diseases secondary to atherosclerosis and thrombosis are also the main cause of morbidity and mortality in Europe. Advances in conservative treatment as well as interventional and surgical revascularization have improved the prognosis of CVD patients. However, these different types of treatment do not cure, but only delay vital complications underlying the palliative character of present therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
American Heart Association (2000) Heart and stroke statistical update 2000
Dumont DJ, Fong GH, Puri MC, Gradwohl G, Alitalo K, Breitman ML (1995) Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn 203:80–92
Bussolino F, Mantovani A, Persico G (1997) Molecular mechanisms of blood vessel formation. Trends Biochem Sci 22:251–256
Risau W (1997) Mechanisms of angiogenesis. Nature 386:671–674
Schaper W, Scholz D (1997) Growth and remodeling of coronary collateral vessels. In: LaFont A, Topol EJ (eds) Arterial remodeling: a critical factor in restenosis. Kluwer, Boston, pp 31–48
Domini R (1968) Clasificación nosologica de los vasos colaterales arteriales en relación con las progresivas modificaciones de la tectónica parietal inducida por la nueva hemodinámica. Estudio de arteriografia clÃnica comprada. AngiologÃa 20:124–139
Spalteholz W (1907) Die Koronararterien des Herzens. Verh Anat Ges 21:141; in Anat Anz 30
Spalteholz W (1924) Die Arterien der Herzwand. Hirzel, Leipzig
Longland CJ (1953) The collateral circulation of the limb. Ann R Coll Surg Engl 13:161
Mautz FR, Gregg DE (1937) The dynamics of collateral circulation following chronic occlusion of coronary arteries. Proc Soc Exp Biol Med 36:797
Baroldi G, Mantero O, Scomazzoni G (1956) The collaterals of the coronary arteries in normal and pathologic hearts. Circ Res 4:223–229
Fulton WFM (1965) The coronary arteries. Thomas, Springfield, Illinois
Schaper W (1971) The collateral circulation of the heart. In: Schaper W (ed) The collateral circulation of the heart. Elsevier North Holland, Amsterdam
Scholz D, Ito W, Fleming I, Deindl E, Sauer A, Babiak A, Bühler A, Wiesnet M, Busse R, Schaper J, Schaper W (2000) Ultrastructure and molecular histology of rabbit hindlimb collateral artery growth. Virchows Arch 436:257–270
Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner J (1998) Mouse model of angiogenesis. Am J Pathol 152:1667–1679
Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, Isner JM (1998) Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97:99–107
Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM (1998) Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101:2567–2578
Ito WD, Arras M, Scholz D, Winkler B, Htun P, Schaper W (1997) Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol 273:H1255–H1265
Folkman J, D’Amore PA (1996) Blood vessel formation: what is its molecular basis? Cell 87:1153–1155
Schmidt RF, Thews G (1997) Physiologie des Menschen. Springer, Berlin Heidelberg New York
Scholz D, Devaux B, Hirhe A, Pöztsch B, Kropp B, Schaper W, Schaper J (1996) Expression of adhesion molecules is specific and time-dependent in cytokine stimulated endothelial cells in culture. Cell Tissue Res 284:415–423
Cheng J, Wung B, Chao Y, Wang D (1996) Cyclic strain enhances adhesion of monocytes to endothelial cells by increasing intercellular adhesion molecule-1 expression. Hypertension 28:386–391
Chien S, Li S, Shyy YJ (1998) Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension 31:162–169
Ingber DE (1997) Tensegrity: the architectural basis of cellular mechanotransduction. Annu Rev Physiol 59:575–599
Maniotis AJ, Chen CS, Ingber DE (1997) Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc Natl Acad Sci USA 94:849–854
Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:311–314
Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W (1998) Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 101:40–50
Catoretti G, Becker MHG, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357–363
Gerdes J (1990) Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol 1:199–206
Schlüter K, Duchrow M, Wohlenberg C, Becker MHG, Key G, Flad H-D, Gerdes J (1993) The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 123:513–522
Shiraishi T (1990) Cell kinetic analysis of brain tumors using the monoclonal antibody Ki-67: in vitro and in situ study. Acta Med Okayama 44:187–201
Wolf C, Cai W-J, Vosschulte R, Koltai S, Mousavipour D, Scholz D, Afsah-Hedjri A, Schaper W, Schaper J (1998) Vascular remodeling and altered protein expression during growth of coronary collateral arteries. J Mol Cell Cardiol 30:2291–2305
Ziegelhoeffer T, Hoefer IE, van Royen N, Buschmann IR (1999) Effective reduction in collateral artery formation through matrix metalloproteinase inhibitors. Circulation 100 [Suppl I]:3719
Deindl E, Fernández B, HIE, van Royen N, Scholz D, Schaper W (1999) Arteriogenesis, collateral blood vessels, and their development. In: Rubanyi GM (ed) Angiogenesis in health and disease. Dekker, New York, pp 31–46
Buschmann I, Ito W, Höfer I, Scholz D, Schaper W (1998) Granulocyte-Macrophage-Colony-Stimulating-Factor (GM-CSF) fördert das Kollateralarterienwachstum durch prolongierte Macrophagenaktivität. Z Kardiol 87 [Suppl 1]:17
Okada-Ban M, Thiery JP, Jouanneau J (2000) Fibroblast growth factor-2. Int J Biochem Cell Biol 32:263–267
Engleka KA, Maciag T (1999) Molecular mechanisms of the fibroblast growth factor family. In: Ware JA, Simons M (eds) Angiogenesis and cardiovascular disease. Oxford University Press, New York, pp 79–100
Htun P, Ito WD, Hoefer IE, Schaper J, Schaper W (1998) Intramyocardial infusion of FGF-1 mimics ischemic preconditioning in pig myocardium. J Mol Cell Cardiol 30:867–877
Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P (1992) Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 16:181–191
Ferrara N, Gerber HP (1999) The vascular endothelial growth factor family. In: Ware JA, Simons M (eds) Angiogenesis and cardiovascular disease. Oxford University Press, New York, pp 101–127
Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18:3964–3972
Helish A, Schaper W (2000) Angiogenesis and arteriogenesis — not yet for prescription. Z Kardiol 89:239–244
Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes JF (1996) Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb (see comments). Lancet 348:370–374
Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JM (1998) Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia (see comments). Circulation 97:1114–1123
Isner JM, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O, Razvi S, Symes JF (1998) Treatment of thromboangiitis obliterans (Buerger’s disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 28:964–973
Henry TD, Annex BH, Azrin MA, McKendall GR, Willerson JT, Hendel RC, Giordano F, Klein R, Gibson M, Berman DS, Luce CA, McCluskey ER (1999) Final results of the VIVA trial of rhVEGF for human therapeutic angiogenesis. Circulation 100 [Suppl I]:I476
Blumgart HL, Schlesinger MJ, Davis D (1940) Studies on the relation of the clinical manifestations of angina pectoris, coronary thrombosis and myocardial infarction to the pathological findings, with particular reference to the significance of collateral circulation. Am Heart J 19:1–19
Fernandez B, Bueler A, Wolfram S, Kostin S, Espanion G, Franz WM, Nieman H, Doevedans PA, Schaper W, Zimmermann R (2000) Transgenic myocardial overexpression of fibroblast growth factor-1 increases coronary artery density and branching. Circ Res 87:207–213
Thirumurti V, Shou M, Hodge E, Goncalves L, Epstein SE, Lazarous DF, Unger EF (1998) Lack of efficacy of intravenous basic fibroblast growth factor in promoting myocardial angiogenesis. J Am Coll Cardiol 31:54A
Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam S, Hunsberger S, Robison WG Jr, Stiber JA, Correa R, Epstein SE et al (1995) Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91:145–153
Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz M, Correa R, Klingbeil C, Epstein SE (1994) Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 266:H1588–H1595
Mack CA, Patel SR, Schwarz EA, Zanzonico P, Hahn RT, Ilercil A, Devereux RB, Goldsmith SJ, Christian TF, Sanborn TA, Kovesdi I, Hackett N, Isom OW, Crystal RG, Rosengart TK (1998) Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 115:168–176; discussion 176–177
Sanborn TA, Tarazona N, Deutsch E, Lee L, Hackett N, El-Sawy T, Crystal RG, Rosengart TK (1999) Percutaneous endocardial gene therapy: in vivo gene transfer and expression. J Am Coll Cardiol 33 [Suppl A]:262A
Kornowski R, Fuchs S, Leon MB, Epstein SE (2000) Delivery strategies to achieve therapeutic myocardial angiogenesis. Circulation 101:454–458
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Scholz, D., Ziegelhöffer, T., Friedrich, C. (2002). Molecular Biology of Collateral Circulation. In: Lanzer, P., Topol, E.J. (eds) Pan Vascular Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56225-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-56225-9_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62565-7
Online ISBN: 978-3-642-56225-9
eBook Packages: Springer Book Archive